Clinical Trials on Thrombosis in Belgium

Total 146 results

Bayer

Recruiting

A Study to Learn More About How Well BAY3018250 Works and How Safe it is for People With Proximal Deep Vein Thrombosis (SIRIUS)

Thrombolysis | Symptomatic Proximal Deep Vein Thrombosis

Belgium, France, Italy, Netherlands, Canada, Germany, Czechia
Diakron Pharmaceuticals

Completed

A Healthy Volunteer Study to Evaluate for a Single Dose of 4 Different Tablets of DPOC-4088 the Absorption and Elimination From the Body and the Potential Effect on Blood Clotting

Deep Vein Thrombosis Leg

Belgium
Brugmann University Hospital

Completed

Use of the Venous Coupler in Breast Reconstruction by Means of a Deep Inferior Epigastric Perforator: Reduction of Surgery Length and Venous Thromboses ?

Mammary Reconstruction

Belgium
Bayer
Janssen Scientific Affairs, LLC

Completed

Belgian Real Life Non-interventional Study (NIS) in Patients Treated With Xarelto Following an Acute Deep Vein Thrombosis (DVT) (BOX-DVT)

Venous Thrombosis

Belgium
Diagnostica Stago

Active, not recruiting

ThRombosis ExclUsion STudy (TRUST)

Venous Thromboembolism | Pulmonary Embolism | Deep Venous Thromboses

United States, Spain, France, Belgium, Italy
Diakron Pharmaceuticals
Drug Research Unit Ghent, Ghent, Belgium; Kinesis Pharma B.V.

Terminated

A Healthy Volunteer Study to Investigate the Blood Concentrations, the Effect on Blood Clotting and the Safety of Multiple Doses of DPOC-4088 Tablets in Different Doses.

Deep Vein Thrombosis Leg | Stroke (in Patients With Atrial Fibrillation)

Belgium
Universitaire Ziekenhuizen KU Leuven
Deutsches Herzzentrum Muenchen; European Union

Unknown

PRESTIGE: PREvention of Stent Thrombosis by an Interdisciplinary Global European Effort (PRESTIGE)

Coronary Artery Stent Thrombosis

Belgium
Bristol-Myers Squibb

Completed

Safety and Tolerability Study of BMS-986177 in Healthy Subjects

Thrombosis

Belgium
Universitaire Ziekenhuizen KU Leuven

Withdrawn

Surgical Stabilizer Assisted RVC With rtPA for CRVO

Central Retinal Vein Occlusion

Belgium
Universitaire Ziekenhuizen KU Leuven
KU Leuven

Completed

Phase I RVC With Ocriplasmin for CRVO (RVC_CRVO)

Central Retinal Vein Occlusion

Belgium
Bayer
Regeneron Pharmaceuticals

Completed

Retrospective Data Analysis of Patients Treated for Macular Edema Due to Central Retinal Vein Occlusion (RETRO CRVO)

Retinal Vein Occlusion

Belgium
Allergan

Completed

Retrospective Data Collection Study in Patients Receiving Two or More OZURDEX® Injections for Macular Oedema Secondary to Retinal Vein Occlusion

Retinal Vein Occlusion | Macular Oedema

Belgium
Cliniques universitaires Saint-Luc- Université...

Completed

Platelet Acetyl Coenzyme A Carboxylase Phosphorylation in Coronary Artery Disease (ACCTHEROMA)

Coronary Artery Disease | Acute Coronary Syndrome | Coronary Thrombosis

Belgium
Jessa Hospital

Completed

COVID-19 and Deep Venous Thrombosis

COVID-19 | Deep Vein Thrombosis (DVT)/Thrombophlebitis

Belgium
AZ Delta
Alexion

Completed

Retrospective Chart Review Screening Algorithm to Assess the Prevalence of PNH-clones

Thrombosis | PNH

Belgium
University Hospital, Ghent

Completed

Evaluating Dose Regimen of Intravenous Unfractionated Heparin and Low Molecular Weight Heparin in Critical Ill Patients Versus Critical Ill COVID-19 Patients Using Anti-Xa Levels.

COVID-19 | Critical Illness | Deep Vein Thrombosis | Anticoagulants and Bleeding Disorders

Belgium
University Medical Center Groningen

Completed

Diagnostic Algorithm in Suspected Upper Extremity Deep Vein Thrombosis (Armour)

Suspected Upper Extremity Deep Vein Thrombosis

Austria, Netherlands, Italy, Belgium, Switzerland, Germany, United States
Bayer
Janssen Research & Development, LLC

Completed

A Non-interventional Study on Xarelto for Treatment of Venous Thromboembolism (VTE) and Prevention of Recurrent VTE in Patients With Active Cancer (COSIMO)

Venous Thrombosis and Pulmonary Embolism

Italy, Germany, United Kingdom, France, Belgium, Canada, Netherlands, Spain, Denmark, Australia
Cliniques universitaires Saint-Luc- Université...

Completed

Prevalence and Causes of Preventable and Serious Adverse Drug Reactions Related to the Use of Oral Anticoagulants (ADR-OAC)

Hemorrhage | Embolism and Thrombosis

Belgium
Bayer
Janssen Research & Development, LLC

Completed

Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy (XALIA)

Venous Thrombosis | Deep Vein Thrombosis

Switzerland, France, Germany, Hungary, Spain, Sweden, Austria, Czech Republic, Italy, Moldova, Republic of, Slovenia, Ukraine, United Kingdom, Israel, Portugal, Belgium, Denmark, Greece, Netherlands, Canada, Norway
Sanofi

Completed

Bioequipotency Study of Idrabiotaparinux and Idraparinux in Patients With Deep Venous Thrombosis of the Lower Limbs (EQUINOX)

Deep Venous Thrombosis

France, Mexico, Turkey, Italy, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Czech Republic, Denmark, Israel, Netherlands, New Zealand, Poland, Russian Federation, South Africa, Spain
LeMaitre Vascular
Avania

Recruiting

A PMCF Study to Confirm the Performance and Safety of the LeMaitre® TufTex Single Lumen Embolectomy Catheter (SLC)

Arterial Thromboembolism

Belgium, Germany, Switzerland
Daiichi Sankyo, Inc.

Completed

Cancer Venous Thromboembolism (VTE)

Cancer | Venous Thromboembolism (VTE) | Deep Vein Thrombosis (DVT) | Pulmonary Embolism (PE)

United States, Netherlands, Italy, Belgium, France, Hungary
OncoRadiomics
Centre Hospitalier Universitaire de Liege

Completed

External Validation of a Deep Learning Based Model for Pulmonary Embolism Detection on Chest CT Scans

Pulmonary Embolism

Belgium
University Hospital, Ghent

Active, not recruiting

Extracorporeal Life Support and Modification of Hemostasis (ELMOH)

Thrombosis | Bleeding Disorder | Extra Corporeal Life Support

Belgium, Germany
Crux Biomedical

Completed

Crux Biomedical Evaluation of the Crux Inferior Vena Cava Filter System 3 ("RETRIEVE 3") (RETRIEVE 3)

Pulmonary Embolism

Belgium
AorticLab Srl
Meditrial Europe Ltd.

Completed

NAUTILUS CE-mark Trial of the FLOWer Cerebral Embolic Protection Device (NAUTILUS)

Aortic Valve Stenosis | Intracranial Embolism and Thrombosis

Italy, Belgium
Daiichi Sankyo, Inc.

Completed

Study to Assess the Safety, Pharmacokinetics/Dynamics of DS-1040b in Subjects With Acute Submassive Pulmonary Embolism

Pulmonary Embolism | Thrombotic Disease

Netherlands, Spain, United States, France, Austria, Belgium, Germany, Italy
Boston Scientific Corporation
Novate Medical

Completed

The SENTRY Clinical Study (SENTRY)

Deep Vein Thrombosis | Pulmonary Embolism

United States, Chile, Belgium
Bayer
Janssen Scientific Affairs, LLC

Completed

Belgian Real Life Non-interventional Study (NIS) on Xarelto in Non-valvular Atrial Fibrillation (AF) Patients Treated for the Prevention of Stroke and Systemic Embolism (BOX-AF)

Atrial Fibrillation

Belgium
University Hospital Inselspital, Berne

Completed

Independent OCT Registry on Very Late Bioresorbable Scaffold Thrombosis (INVEST)

Drug-Eluting Stents | Coronary Thrombosis | Tomography, Optical Coherence

Austria, Belgium, France, Germany, Hong Kong, Italy, Netherlands, Singapore, Spain, Switzerland
Boston Scientific Corporation
KIKA

Completed

Safety and Efficacy of Express LD to Treat Stenosed or Occlusive Atherosclerotic Disease in Iliac Arteries (MELODIE)

Thrombosis | Intermittent Claudication | Arterial Occlusive Disease | Atherosclerotic Disease

Belgium, Canada, Czech Republic, Netherlands, Poland
Bayer
Janssen Research & Development, LLC

Completed

Phase I Study on Rivaroxaban Granules for Oral Suspension Formulation in Children

Thrombosis

Canada, United States, Belgium, Spain, Italy, France, Finland, Hungary
Assistance Publique - Hôpitaux de Paris
Bristol-Myers Squibb

Active, not recruiting

API-CAT STUDY for APIxaban Cancer Associated Thrombosis (API-CAT)

Cancer-associated Thrombosis

France, Spain, Netherlands, Belgium, Austria, Greece, Switzerland, Canada, Italy, Poland, United Kingdom
Population Health Research Institute

Completed

PeriOperative ISchemic Evaluation-3 Trial (POISE-3)

Venous Thrombosis | Arterial Thrombosis | Perioperative Bleeding

Spain, United States, Germany, Hong Kong, Australia, New Zealand, Canada, United Kingdom, Austria, Belgium, Malaysia, Brazil, Netherlands, China, Pakistan, Russian Federation, France, Chile, Denmark, India, Italy, Poland, South Africa
Bayer

Completed

Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Proximal Deep Vein Thrombosis(ODIXa-DVT)

Venous Thrombosis | Deep Vein Thrombosis

Belgium, Israel, Italy, Spain, Switzerland, Colombia, New Zealand, Hungary, Canada, Sweden, Austria, Czechia, Germany, Poland, Netherlands, Peru, South Africa, Australia, Brazil
Academisch Medisch Centrum - Universiteit van Amsterdam...
Netherlands Organisation for Scientific Research; Aspen Pharma; CHU of Saint... and other collaborators

Completed

Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy (Highlow)

Pulmonary Embolism | Deep Venous Thrombosis

Norway, Netherlands, Denmark, France, Belgium, Ireland, United States, Canada, Russian Federation, Spain
Janssen Research & Development, LLC
Bayer

Completed

Pharmacokinetic, Pharmacodynamic, Safety, and Efficacy Study of Rivaroxaban for Thromboprophylaxis in Pediatric Participants 2 to 8 Years of Age After the Fontan Procedure (UNIVERSE)

Thrombosis

United States, Spain, Argentina, Malaysia, Japan, Belgium, Canada, Netherlands, Brazil, Mexico
St. Antonius Hospital

Active, not recruiting

Periprocedural Continuation Versus Interruption of Oral Anticoagulant Drugs During Transcatheter Aortic Valve Implantation (POPular PAUSE TAVI)

Myocardial Infarction | Stroke | Bleeding | Aortic Valve Stenosis | Aortic Valve Disease | Thrombosis Embolism | Vascular Complications

Netherlands, Ireland, Belgium, Denmark, Italy, Luxembourg
Jessa Hospital

Completed

Impact of an Intensified Thromboprofylaxis Protocol in COVID-19

Thromboembolism | COVID19

Belgium
Bristol-Myers Squibb

Completed

Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery (ADVANCE-2)

Deep Vein Thrombosis | Pulmonary Embolism

Italy, Korea, Republic of, China, Spain, South Africa, Colombia, Austria, France, Germany, Israel, Russian Federation, Denmark, Belgium, Singapore, Brazil, Mexico, Norway, Philippines, Poland, Ukraine, India, Malaysia, Hungary, Chile, Czech... and more
Sanofi

Completed

Clinical Study Assessing Idrabiotaparinux Sodium Injections Once-weekly in Pulmonary Embolism Therapeutic Approach (CASSIOPEA)

Embolism | Thrombosis

United States, France, Canada, Brazil, Poland, Ukraine, Italy, Netherlands, Portugal, Spain, Sweden, Turkey, Bulgaria, Estonia, India, Philippines, Belgium, Czech Republic, Mexico, Argentina, Croatia, Denmark, Egypt, Israel, Norway, United... and more
Sanofi

Completed

SR34006 Compared to Placebo in Patients Who Have Completed 6 Months of Treatment for Symptomatic Pulmonary Embolism or Deep Vein Thrombosis

Deep Vein Thrombosis | Pulmonary Embolism

United Kingdom, New Zealand, United States, Canada, Australia, Austria, Belgium, Brazil, Czech Republic, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, South Africa, Spain, Sweden
Academisch Medisch Centrum - Universiteit van Amsterdam...

Completed

Tumor-educated Platelets in Venous Thromboembolism

Neoplasms | Venous Thromboembolism

Spain, Netherlands, Belgium, Italy, Canada, Germany
Bristol-Myers Squibb

Completed

Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3)

Deep Vein Thrombosis | Pulmonary Embolism

Australia, Mexico, United Kingdom, United States, China, Spain, Denmark, France, Hungary, Israel, Russian Federation, Canada, Belgium, Argentina, Norway, Poland, Ukraine, India, Germany, Romania, Sweden
Chiesi Farmaceutici S.p.A.

Terminated

Efficacy and Safety of CUSA-081 in the Restoration of Central Venous Access Device (CVAD) Functionality (READY 1)

Thrombosis | Catheter Occlusion

United States, Argentina, Belgium, Czechia, Poland, Romania, Spain
St. Antonius Hospital
Daiichi Sankyo, Inc.

Recruiting

What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI? (WOEST-3)

Myocardial Infarction | Coronary Artery Disease | Stroke | Embolism | Atrial Fibrillation | Bleeding | Acute Coronary Syndrome | Atrial Flutter | NSTEMI - Non-ST Segment Elevation MI | Stent Thrombosis | STEMI - ST Elevation Myocardial Infarction

Belgium, Netherlands
University Hospital, Brest
University Hospital, Antwerp; Leiden University Medical Center; Insel Gruppe...

Recruiting

Safety and Efficiency of the YEARS Algorithm Versus Computed Tomography Pulmonary Angiography Alone for Suspected Pulmonary Embolism in Patients With Malignancy (HYDRA)

Cardiovascular Diseases | Vascular Diseases | Respiratory Tract Diseases | Lung Diseases | Cancer | Embolism | Embolism and Thrombosis | Pulmonary Embolism | Diagnosis

Netherlands, Spain, France, Switzerland, Italy, Belgium
Abbott Medical Devices

Completed

XIENCE V: SPIRIT WOMEN Sub-study

Myocardial Ischemia | Coronary Artery Disease | Coronary Arteriosclerosis | Stent Thrombosis | Vascular Disease | Coronary Artery Stenosis | Total Coronary Occlusion | Coronary Artery Restenosis

Italy, Norway, Switzerland, Denmark, Spain, Poland, Belgium, Argentina, Austria, Brazil, France, Germany, Hungary, Latvia, Netherlands
GlaxoSmithKline

Completed

Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate Cancer

Thrombosis, Venous

Netherlands, Belgium, Germany, Canada, Slovenia, Italy, Hungary, Poland, Russian Federation, Czech Republic, France

Clinical Trials on Thrombosis in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guatemala

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations